|
||
| |||||||
|
Nonlinear Dynamics announces another year of record figures Tuesday
19th October 2004 (Newcastle upon Tyne, UK)
Nonlinear Dynamics, a leading provider of bioinformatics solutions, today
announced its year-end results for 2003/4, as audited by Deloitte and Touche.
The company has achieved record turnover, record profits and record assets for
the financial year. Duncan
Barrie, Finance Director of Nonlinear Dynamics, said, “We are delighted to
announce record trading activity, profitability and balance sheet strength for
the financial year 2003/4. Nonlinear has continued to build on its well
established reputation as a profitable developer of high quality bioinformatics
software. Profits in excess of $1 million mark another milestone in
Nonlinear’s history. “The
Life Science market continues to be volatile and, coupled with fluctuations in
the value of the US dollar, the industry has proved a challenging business
environment. By maintaining focus on the fundamentals of world class products
and services, we have achieved yet another record year. We continue to
strengthen our business and to demonstrate durability in a dynamic market
place.” David
Wilkinson, Partner of Deloitte and Touche Newcastle, added, “Already
established as one of the UK’s fastest growing technology companies, Nonlinear
Dynamics is now making a real impact as a serious contender in the global Life
Sciences Industry. These latest figures reveal that Nonlinear is consistently
competing and succeeding against an international field from year to year. The
company is demonstrating increasing levels of sustainability and profitability
and Deloitte and Touche is pleased to see Nonlinear's success translated into
this year's profit margins.” Over
this period, Nonlinear Dynamics conducted a major expansion of its sales
pipeline. Investing in its direct sales team, coupled with new and renegotiated
OEM partnerships, has helped significantly to reinvigorate Nonlinear’s
distribution channels. New or upgraded commercial collaborations for 2003/4
included PerkinElmer Inc., Shimadzu Corporation, Genetix Ltd and Genomic
Solutions Inc.. The
financial year 2003/4 saw numerous new product releases, especially to
Nonlinear’s innovative 2D product range. Updated versions of Progenesis
Workstation and Progenesis Discovery were released, along with upgrades to the
well-established Phoretix 2D Evolution and the launch of 2D Expression.
Nonlinear also strengthened its product portfolio in other bioinformatics
markets with new releases of 1D and 1D Pro, TotalLab and ImageQuant TL. John
Spreadbury, Group Sales and Marketing Director of Nonlinear Dynamics and CEO of
Nonlinear USA Inc, said, “Our new product releases were show-cased at various
high profile events and have been excellently received by the global Life
Science community. Building on this success, we are planning yet more product
releases before the end of this year.” He
added, “These profit figures form the foundation of our continuing commitment
to reinvest heavily in research and development. This consolidates our position as a leading global provider
of bioinformatics software solutions.” -
ENDS - About
Nonlinear Dynamics Ltd
Established
in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics
solutions to the life science industry. The Company’s innovative product
portfolio comprises high-quality analysis and data mining tools for 1D and 2D
electrophoresis gels and microarrays, the core technologies of genomics and
proteomics. Nonlinear sells and supports its products through its UK
headquarters, its USA office, and its global network of partners and OEM
resellers. Contact:
James Sykes, Group Marketing Manager Tel:
+44 191 230 2121; james.sykes@nonlinear.com;
www.nonlinear.com
|
|
| ||||||||